Status:
COMPLETED
Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Leukemia, Myeloid, Acute
Eligibility:
All Genders
60+ years
Phase:
PHASE2
Brief Summary
Our purpose in this study is to explore the feasibility of treatment of non promyelocytic Acute myeloid leukaemia on elderly patients. We select ten patients with age further than 60 with comorbidity ...
Detailed Description
Acute myeloid leukemia is a disease in which characterised by blast further than 20% in bone marrow plus incomplete differentiation. Many of this patients are elderly with age further than 60 years(CA...
Eligibility Criteria
Inclusion
- Elderly patients with non promyelocytic AML
- Performance status (ECOG) 3 or 4
Exclusion
- Age \<60 years
- Elevation of AST OR ALT more than ten times above normal
- Serum bilirubin above 5
- Cr level \> 2
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00850304
Start Date
October 1 2007
End Date
February 1 2008
Last Update
February 24 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hematology-Oncology and SCT Research Center
Tehran, Tehran Province, Iran, 14114